Axis Bank Q4 preview: Citi integration costs may drag bottomline, margin outlook eyed

Axis Bank’s Q4 earnings are expected to be impacted by the one-off costs due to the integration of Citibank India’s business, leading to net losses, according to some analysts. The estimated net loss ranges from INR 54.12bn to INR 55.26bn, while others have excluded the integration costs from their calculations. The bank’s strong core performance […]

Momentum Pick: ICICI Bank to surpass 52-week high; 27% upside seen over long term

ICICI Bank has outperformed BSE Sensex, Nifty50 and banking indices Nifty Bank and BSE Bankex, registering over 21% returns over the past 12 months amid robust Q4 earnings and technical triggers. According to Rajesh Palviya, VP of Technical and Derivatives Research at Axis Securities, the stock is in a strong uptrend across all time frames, […]

How will Bajaj Fin, Maruti, HDFC Life, SBI Life and L&T Tech fare in Q4?

India’s corporate earnings season focuses on Nifty heavyweights Bajaj Finance, Maruti Suzuki, HDFC Life, SBI Life, and L&T Tech. Maruti Suzuki is expected to post a 22% YoY and 12% sequential growth, along with 41% YoY profit growth. Bajaj Finance is predicted to show a 30% YoY growth in consolidated net profit with SBI Life […]

Fosun drops plan to sell stake in Gland Pharma: Report

Shares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had reported, citing sources that Fosun Pharma was considering a sale of Gland Pharma after receiving interest from potential buyers.